CoChat

Inverse Effect of Fluoxetine on Medial Prefrontal Cortex Activation During Reward Reversal in ADHD and Autism

Open access

The DOI matches its Crossref record; 152 of the 155 references it cites were found in a registry or an index, and 2 are not checked yet.

Abstract

Attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) share brain function abnormalities during cognitive flexibility. Serotonin is involved in both disorders, and selective serotonin reuptake inhibitors (SSRIs) can modulate cognitive flexibility and improve behavior in both disorders. Thus, this study investigates shared and disorder-specific brain dysfunctions in these 2 disorders during reward reversal, and the acute effects of an SSRI on these. Age-matched boys with ADHD (15), ASD (18), and controls (21) were compared with functional magnetic resonance imaging (fMRI) during a reversal task. Patients were scanned twice, under either an acute dose of Fluoxetine or placebo in a double-blind, placebo-controlled randomized design. Repeated-measures analyses within patients assessed drug effects. Patients under each drug condition were compared with controls to assess normalization effects. fMRI data showed that, under placebo, ASD boys underactivated medial prefrontal cortex (mPFC), compared with control and ADHD boys. Both patient groups shared decreased precuneus activation. Under Fluoxetine, mPFC activation was up-regulated and normalized in ASD boys relative to controls, but down-regulated in ADHD boys relative to placebo, which was concomitant with worse task performance in ADHD. Fluoxetine therefore has inverse effects on mPFC activation in ASD and ADHD during reversal learning, suggesting dissociated underlying serotonin abnormalities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cercor/bht365

Cites

152 of 154 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Reward reversal learning task: subjects select an image (right/left) by pressing the corresponding button (right/left). If is the choice is correct/incorrect, positive/negative feedback is given. Once the subject has made 4–6 correct responses, the stimulus-reward contingency is reversed. PETs, where incorrect feedback is given for a correct response, are included to prevent subjects from predicting an upcoming reversal trial. The task contains on average 20 reversal trials with 20 interspersed PET trials.
Figure 1. Reward reversal learning task: subjects select an image (right/left) by pressing the corresponding button (right/left). If is the choice is correct/incorrect, positive/negative feedback is given. Once the subject has made 4–6 correct responses, the stimulus-reward contingency is reversed. PETs, where incorrect feedback is given for a correct response, are included to prevent subjects from predicting an upcoming reversal trial. The task contains on average 20 reversal trials with 20 interspersed PET trials.CC BY-NC · PubMed Central
Figure 2. Within-group activation for (A) Healthy controls, (B) adolescents with ADHD under either placebo or Fluoxetine, and (C) adolescents with ASD under either placebo or Fluoxetine for the contrast of final reversal error–probabilistic error. Axial sections showing within-group brain activation for healthy control boys, boys with ADHD under either placebo or Fluoxetine, and boys with ASD under either placebo or Fluoxetine for the contrast of final reversal error – probabilistic error. Talairach z co-ordinates are indicated for slice distance (in mm) from the intercommissural line. The right side corresponds to the right side of the image.
Figure 2. Within-group activation for (A) Healthy controls, (B) adolescents with ADHD under either placebo or Fluoxetine, and (C) adolescents with ASD under either placebo or Fluoxetine for the contrast of final reversal error–probabilistic error. Axial sections showing within-group brain activation for healthy control boys, boys with ADHD under either placebo or Fluoxetine, and boys with ASD under either placebo or Fluoxetine for the contrast of final reversal error – probabilistic error. Talairach z co-ordinates are indicated for slice distance (in mm) from the intercommissural line. The right side corresponds to the right side of the image.CC BY-NC · PubMed Central
Figure 3. (A) Between-group and within-patient comparisons: axial sections showing the between-group ANCOVA findings between controls and patients under placebo. Shown underneath are the statistical measures of BOLD response for each of the 3 groups for each of the brain regions that showed a significant group effect. mPFC, medial prefrontal cortex. Error bars indicate standard error. (B) Axial sections for the between-group ANCOVA comparison between controls and patients under Fluoxetine. (C) Axial sections showing within-patient group by medication interaction effects. Talairach z co-ordinates are indicated for slice distance (in mm) from the intercommissural line. The right side of the image corresponds to the right side of the brain.
Figure 3. (A) Between-group and within-patient comparisons: axial sections showing the between-group ANCOVA findings between controls and patients under placebo. Shown underneath are the statistical measures of BOLD response for each of the 3 groups for each of the brain regions that showed a significant group effect. mPFC, medial prefrontal cortex. Error bars indicate standard error. (B) Axial sections for the between-group ANCOVA comparison between controls and patients under Fluoxetine. (C) Axial sections showing within-patient group by medication interaction effects. Talairach z co-ordinates are indicated for slice distance (in mm) from the intercommissural line. The right side of the image corresponds to the right side of the brain.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Research works printed but not linked: 8

  1. Barrickman, 1991, Journal of the American Academy of Child and Adolescent Psychiatry, 30, 762
  2. 2007, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 33, 2007
  3. 2013, Journal of Cognitive Neuroscience, 25, 807
  4. Chugani, 1999, Annals of neurology, 45, 287, 10.1002/1531-8249(199903)45:3<287::aid-ana3>3.0.co;2-9 · doi:10.1002/1531-8249(199903)45:3<287::aid-ana3>3.0.co;2-9
  5. Cools, 2002, Journal of Neuroscience, 22, 4563
  6. 2013, Autism, 0, 1
  7. 2012, EURO NEUROPSYCHOPHARM, 23, 1151
  8. 2010, Cochrane database of systematic reviews (Online), 8, 1

Cited by

See all 63

Metadata

Authors
Chantiluke, K., Barrett, N., Giampietro, V., Brammer, M., Simmons, A., Murphy, D. G., & Rubia, K.
Affiliations
  • South London and Maudsley NHS Foundation Trust (GB)
  • King's College London (GB)
Corresponding author
Rubia, K.
Venue
Cerebral Cortex
Published
2014-01-22
Volume
25
Issue
7
Pages
1757-1770
ISSN
  • 1047-3211 (ISSN-L)
  • 1460-2199
OpenAlex
W2102357568
Cited by
59
References
155
Citations by year
2026: 3 · 2025: 4 · 2024: 8 · 2023: 5 · 2022: 2 · 2021: 7 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 5 · 2016: 5 · 2015: 7 · 2014: 2
FWCI
4.84
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Cerebral Cortex (publishedVersion, other-oa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion, cc-by-nc)
Funders
  • South London and Maudsley NHS Foundation Trust
  • National Institute for Health and Care Research (RP-PG-0606-1045)
  • King's College London
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
fluoxetine, selective serotonin reuptake inhibitors, attention deficit hyperactivity disorder, autism spectrum disorder, medial prefrontal cortex, cognitive flexibility, serotonin, precuneus, reversal learning
MeSH terms
Adolescent, Attention Deficit Disorder with Hyperactivity, Autistic Disorder, Brain Mapping, Child, Double-Blind Method, Fluoxetine, Humans, Magnetic Resonance Imaging, Male, Neuropsychological Tests, Reversal Learning, Reward, Selective Serotonin Reuptake Inhibitors, Prefrontal Cortex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.